Health authorities in Democratic Republic of Congo (DRC) informed that they plan to introduce a second Ebola vaccine, manufactured by Johnson & Johnson, to counter the second-worst outbreak of the deadly virus.
https://twitter.com/reutersafrica/status/1175372732596465664?s=21
The team overseeing Congo’s Ebola response did not reveal when exactly the J&J vaccine would be employed. It will complement another vaccine manufactured by Merck, which has been administered to more than 225,000 people since August 2018. Unlikely fhe J&J vaccine requires two injections eight weeks apart, unlike the Merck product, which requires a single shot.
https://twitter.com/reutersafrica/status/1175372732596465664?s=21
According to the Congolese authorities, they will offer J&J vaccine to Congolese traders who cross into Rwanda and then to residents of the province neighbouring the epicentre of the outbreak to “create a corridor of immunised people”.
AFRICA DIPLOMATIC 